BLUE BELL, Pa.–(BUSINESS WIRE)–IPS-Integrated Project Services, LLC, a leading provider of engineering, procurement, construction management, and validation services, proudly announces the appointment of Gordon Nicholson as the Regional Director, ANZ (Australia, New Zealand), to lead IPS’ new Melbourne, Australia office.
Throughout his career, Gordon has successfully led and contributed to a multitude of projects, spanning the design and construction of various life science facilities including Cell and Gene Therapies, from research labs to large-scale manufacturing plants. Before joining IPS, Gordon served in leadership roles across the APAC region from Singapore to Shanghai and Melbourne. Having worked with clients like Sanofi, Bayer, GSK, NovoNordisk and AstraZeneca, he has developed a vast professional network and an in-depth understanding of the region’s dynamics.
“Gordon’s appointment as Regional Director, ANZ allows us to further support our clients in bringing life-changing therapies to patients in Australia and beyond,” said Matthew Shippey, Managing Director, APAC. “The strategic hire of Gordon is the first step of the 2024 regional transformation plan. His commitment to operational efficiency, coupled with years of experience in the APAC market, will be integral to IPS’s ongoing success and expansion in Australia.”
Working closely with APAC leadership, Gordon will have key responsibilities crucial for the company’s success. Gordon will spearhead business development, leveraging his extensive industry network and over three decades of experience to identify strategy opportunities and cultivate valuable partnerships. His expertise will play a pivotal role in driving project and operational excellence, ensuring that IPS continues to deliver client-centered and cutting-edge solutions. Gordon’s leadership will be instrumental in fostering growth within the Australian market, positioning the company as a leading force in the life sciences and pharmaceutical manufacturing sectors.
IPS, a Berkshire Hathaway Company, is a global leader in developing innovative business solutions for the biotechnology and pharmaceutical industries. Through operational expertise and industry-leading knowledge, skill, and passion, IPS provides consultancy services, architecture, engineering, project controls, construction management, and compliance services that allow clients to develop and manufacture life-impacting products. Its newest acquisition, Linesight specializes in cost, schedule, risk, program, and project management services in various market sectors, including data centers, life sciences, and high-tech industrial. With the addition of Linesight, IPS has over 3,400 professionals in over 45 offices across 17 countries in the Americas, Europe, and Asia Pacific. For further information, please visit www.ipsdb.com.